DE3381494D1 - Immunogen-lage des poliovirus enthaltende peptide und dns enthaltend nukleotidfragmente die fuer diese peptide kodieren. - Google Patents

Immunogen-lage des poliovirus enthaltende peptide und dns enthaltend nukleotidfragmente die fuer diese peptide kodieren.

Info

Publication number
DE3381494D1
DE3381494D1 DE8383402310T DE3381494T DE3381494D1 DE 3381494 D1 DE3381494 D1 DE 3381494D1 DE 8383402310 T DE8383402310 T DE 8383402310T DE 3381494 T DE3381494 T DE 3381494T DE 3381494 D1 DE3381494 D1 DE 3381494D1
Authority
DE
Germany
Prior art keywords
peptides
poliovirus
immunogenic
encode
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8383402310T
Other languages
English (en)
Inventor
Marc Girard
Der Werf Sylvie Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur de Lille
Original Assignee
Institut Pasteur de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR838310778A external-priority patent/FR2548212B1/fr
Application filed by Institut Pasteur de Lille filed Critical Institut Pasteur de Lille
Application granted granted Critical
Publication of DE3381494D1 publication Critical patent/DE3381494D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
DE8383402310T 1982-11-30 1983-11-30 Immunogen-lage des poliovirus enthaltende peptide und dns enthaltend nukleotidfragmente die fuer diese peptide kodieren. Expired - Lifetime DE3381494D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8220115 1982-11-30
FR838310778A FR2548212B1 (fr) 1983-06-29 1983-06-29 Peptides comportant un site immunogene du poliovirus et adns contenant des sequences nucleotidiques codant pour ces peptides

Publications (1)

Publication Number Publication Date
DE3381494D1 true DE3381494D1 (de) 1990-05-31

Family

ID=26223167

Family Applications (2)

Application Number Title Priority Date Filing Date
DE89102888T Expired - Fee Related DE3382718T2 (de) 1982-11-30 1983-11-30 Peptide, die eine Immunogen-Lage des Poliovirus des Sabin-Stammes enthalten.
DE8383402310T Expired - Lifetime DE3381494D1 (de) 1982-11-30 1983-11-30 Immunogen-lage des poliovirus enthaltende peptide und dns enthaltend nukleotidfragmente die fuer diese peptide kodieren.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE89102888T Expired - Fee Related DE3382718T2 (de) 1982-11-30 1983-11-30 Peptide, die eine Immunogen-Lage des Poliovirus des Sabin-Stammes enthalten.

Country Status (6)

Country Link
US (3) US4694072A (de)
EP (1) EP0110791B1 (de)
JP (1) JPH07133293A (de)
CA (1) CA1230299A (de)
DE (2) DE3382718T2 (de)
WO (1) WO1988003950A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2521165A1 (fr) * 1982-02-08 1983-08-12 Pasteur Institut Fragments d'adn codant pour un peptide immunogene susceptible d'introduire in vivo la synthese d'anticorps anti-poliovirus
EP0105346B1 (de) * 1982-04-14 1991-11-13 BITTLE, James L. Künstliches pikornavirusantigen
US4694071A (en) * 1982-10-11 1987-09-15 National Research Development Corporation Polypeptides useful in vaccination against enteroviruses
US5198536A (en) * 1982-11-30 1993-03-30 Institut Pasteur Peptides comprising an immunogenic site of poliovirus and DNAs containing nucleotide sequences coding for these peptides
EP0119153A3 (de) * 1983-03-11 1985-08-28 The Research Foundation Of State University Of New York Synthetische Impfstoffe
GB8421282D0 (en) * 1984-08-22 1984-09-26 Connaught Lab Multispecific antigenic proteins
GB8508685D0 (en) * 1985-04-03 1985-05-09 Minor P D Peptides
JPS63229612A (ja) * 1987-03-19 1988-09-26 Fuji Photo Film Co Ltd 磁気記録媒体
FR2623817B1 (fr) * 1987-11-26 1990-05-04 Pasteur Institut Sondes pour la detection d'enterovirus par hybridation moleculaire et pour la discrimination entre des poliovirus et d'autres enterovirus
DE3841763A1 (de) * 1988-12-12 1990-06-13 Basf Ag Neue tnf-peptide
JP3355351B2 (ja) * 1989-02-24 2002-12-09 ユーロジェン・ホールディング・ソシエテ・アノニム 遺伝的に工作されたイムノグロブリン

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4554101A (en) * 1981-01-09 1985-11-19 New York Blood Center, Inc. Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
US4719177A (en) * 1981-04-20 1988-01-12 Massachusetts Institute Of Technology Production of complementary DNA representing RNA viral sequences by recombinant DNA methods and uses therefor
FR2506326A1 (fr) * 1981-05-19 1982-11-26 Pasteur Institut Fragments d'adn portant des parties de l'information genetique des poliovirus, notamment du type pv1, et procede pour leur obtention
NL8102740A (nl) * 1981-06-05 1983-01-03 Nederlanden Staat Virusvaccins en werkwijze ter bereiding daarvan.
FR2521165A1 (fr) * 1982-02-08 1983-08-12 Pasteur Institut Fragments d'adn codant pour un peptide immunogene susceptible d'introduire in vivo la synthese d'anticorps anti-poliovirus
US4591552A (en) * 1982-09-29 1986-05-27 New York Blood Center, Inc. Detection of hepatitis B surface antigen (or antibody to same) with labeled synthetic peptide
US4694071A (en) * 1982-10-11 1987-09-15 National Research Development Corporation Polypeptides useful in vaccination against enteroviruses

Also Published As

Publication number Publication date
WO1988003950A1 (fr) 1988-06-02
DE3382718T2 (de) 1994-05-05
EP0110791A2 (de) 1984-06-13
US4694072A (en) 1987-09-15
EP0110791A3 (en) 1984-07-25
EP0110791B1 (de) 1990-04-25
JPH07133293A (ja) 1995-05-23
US4940781A (en) 1990-07-10
CA1230299A (fr) 1987-12-15
DE3382718D1 (de) 1993-11-11
US5061623A (en) 1991-10-29

Similar Documents

Publication Publication Date Title
IT8319396A0 (it) Procedimento per il trattamento termico per leghe nicraly per uso come materiali per forni ceramici e forni da trattamento termico.
DE10299049I1 (de) Rekombinante Viren.
DE3789413D1 (de) Lymphokin-ähnliche Peptide.
DE3850179D1 (de) Vibratoranordnung und diese verwendendes Vibrotherapeutisches Gerät.
EP1021202A4 (de) Immunogene peptide aus dem hpv e7 protein
DE3381494D1 (de) Immunogen-lage des poliovirus enthaltende peptide und dns enthaltend nukleotidfragmente die fuer diese peptide kodieren.
DE3782620D1 (de) Gasentladungslampe und diese lampe benutzendes geraet.
NO880518L (no) Dentalsementmateriale.
IT8321093A0 (it) Peptidi.
DK568587A (da) Dna fragmenter indeholdende alkalisk cellulasegen, rekombinante plasmider indeholdende disse dna fregmenter og rekombinante mikroorganismer
DE69004037D1 (de) Apparat zur Wärmebehandlung von kontaminiertem, stückigem Material.
EP0209543A4 (de) Peptidfragmente menschlicher apolipoproteine, typspezifische antikörper und verwendungsverfahren.
FI841288A (fi) Rekombinant-dna-kod foer uttryckning av polypeptid.
DE3778550D1 (de) Fieber- und entzuendungshemmende peptide.
DE3671482D1 (de) Kammer fuer plasma-behandlung.
EP0363436A4 (de) Geklonte gene von protein g-varianten und davon exprimierte protein g-varianten.
DE3381115D1 (de) Dns und diese enthaltendes rekombinantes plasmid.
DE3880520D1 (de) Rekombinantes plasmid fuer die expression von l-phenylalanin-ammonialyase und transformierte staemme, die es enthalten.
ATE52277T1 (de) Immunogen-lage des poliovirus enthaltende peptide und dns enthaltend nukleotidfragmente die fuer diese peptide kodieren.
DE3853743D1 (de) Rekombinanter menschlicher ADF.
DE3777359D1 (de) Aminosaeuresequenz des menschlichen alpha 2-plasmininhibitors und cdns sowie diese aminosaeuresequenz codierende genomische dns.
NO885088D0 (no) Omslagsmateriale, fremgangsmŸte for dets fremstilling og fremgangsmŸte til bruk av materialet.
NL194918B (nl) SDK-peptide, en therapeutische preparaten die deze bevatten.
ATE49609T1 (de) Dns und diese enthaltendes rekombinantes plasmid.
DE59000314D1 (de) Grossraumsilo fuer staubfoermiges und feinkoerniges schuettgut.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee